Ovid Therapeutics Inc. (OVID) Total Return Calculator with Dividends Reinvested

Ovid Therapeutics Inc.

Popular:

The total return for Ovid Therapeutics Inc. (OVID) stock is +667.15% over the past 12 months. So far it's up 28.98% this year. The 5-year total return is -48.05%, meaning $10,000 invested in OVID stock 5 years ago would be worth $5,195 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in OVID 1 year ago, it would be worth $77,586 today — you'd have gained $67,586.

With Dividends Reinvested$77,586+675.86%

Price Only (No DRIP)$77,586+675.86%

Period2025-06-23 → 2026-06-22

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in OVID

1Y$76,715+$66,715 (+667.2%)667.2% CAGR

3Y$5,896-$4,104 (-41.0%)-16.1% CAGR

5Y$5,195-$4,805 (-48.1%)-12.3% CAGR

10Y$1,853-$8,147 (-81.5%)-15.5% CAGR

15Y$1,853-$8,147 (-81.5%)-10.6% CAGR

20Y$1,853-$8,147 (-81.5%)-8.1% CAGR

30Y$1,853-$8,147 (-81.5%)-5.5% CAGR

Ovid Therapeutics Inc. did not pay dividends during this period. Total return = price return.

Loading OVID total return...

As of 2026-06-23

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+28.98%	—	+28.98%	—	$12,898
1Y	+667.15%	667.15%	+667.15%	—	$76,715
3Y	-41.04%	-16.15%	-41.04%	—	$5,896
5Y	-48.05%	-12.28%	-48.05%	—	$5,195
10Y	-81.47%	-15.51%	-81.47%	—	$1,853
15Y	-81.47%	-10.63%	-81.47%	—	$1,853
20Y	-81.47%	-8.08%	-81.47%	—	$1,853
30Y	-81.47%	-5.46%	-81.47%	—	$1,853

Risk & Highlights

Best Year+70.15%2025

Worst Year-75.33%2018

Max Drawdown-34.78%2025-10-03 → 2025-11-13 · Recovered 2026-03-05

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-7.39%	-7.39%	—	+0.41%	-7.8pp
2025	+70.15%	+70.15%	—	+16.64%	+53.5pp
2024	-71.88%	-71.88%	—	+24.00%	-95.9pp
2023	+65.98%	+65.98%	—	+24.81%	+41.2pp
2022	-44.64%	-44.64%	—	-19.95%	-24.7pp

OVID outperformed the S&P 500 by 642.16pp over the past year (+667.15% vs +24.99%).

Loading summary...

OVID Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
OVIDOvid Therapeutics Inc.	$297M	-5.8%	+29.0%	+667.2%	—	-41.0%	-48.1%	-81.5%
ACADACADIA Pharmaceuticals Inc.	$3.8B	+4.5%	-17.3%	-5.8%	—	-9.3%	-16.9%	-42.2%
PRAXPraxis Precision Medicines, Inc.	$8.8B	-11.9%	-1.4%	+557.0%	—	+1611.0%	-12.5%	-32.3%
LGNDLigand Pharmaceuticals Incorporated	$5.3B	+32.2%	+44.6%	+139.8%	—	+255.6%	+117.1%	+139.2%
RAREUltragenyx Pharmaceutical Inc.	$2.9B	+13.4%	+16.3%	-26.5%	—	-45.3%	-71.1%	-49.7%
PTCTPTC Therapeutics, Inc.	$6.7B	+12.6%	+2.9%	+56.6%	—	+88.4%	+76.9%	+1031.5%
FOLDAmicus Therapeutics, Inc.	$4.5B	—	+1.5%	+152.9%	—	+12.1%	+45.9%	+145.2%
KRYSKrystal Biotech, Inc.	$10.1B	+19.3%	+41.0%	+163.5%	—	+179.0%	+433.0%	+3171.2%
ARVNArvinas, Inc.	$499M	-12.6%	-33.1%	+2.7%	—	-73.8%	-90.3%	-52.2%
MDGLMadrigal Pharmaceuticals, Inc.	$11.8B	-3.2%	-14.8%	+78.9%	—	+106.0%	+380.7%	+4415.6%
ZYMEZymeworks Inc.	$1.7B	-5.3%	-13.1%	+83.2%	—	+176.1%	-36.2%	+78.0%

Compare:OVID vs ACAD OVID vs PRAX OVID vs LGND OVID vs ACAD vs PRAX

About OVID Dividend Returns

Ovid Therapeutics Inc. (OVID) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of OVID over the past year?

Ovid Therapeutics Inc. (OVID) delivered a return of 667.15% over the past year. Since OVID does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in OVID be worth today?

A $10,000 investment in Ovid Therapeutics Inc. one year ago would be worth $76,715 today, representing a gain of $66,715.

Q3Does OVID pay dividends?

Ovid Therapeutics Inc. (OVID) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For OVID, the total return equals the price-only return.

Q4Did OVID beat the S&P 500?

Yes, Ovid Therapeutics Inc. (OVID) outperformed the S&P 500 by 642.16 percentage points over the past year. OVID delivered a total return of 667.15%, compared to the S&P 500's 24.99%. This 642.16pp alpha means investors in OVID earned more than a passive S&P 500 index fund.

Q5What is OVID's worst drawdown?

Ovid Therapeutics Inc. (OVID) experienced a maximum drawdown of -34.78% over the past year, declining from its peak on 2025-10-03 to its trough on 2025-11-13. The stock recovered to its prior peak by 2026-03-05. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is OVID's long-term total return over 10, 20, or 30 years?

Here are Ovid Therapeutics Inc. (OVID)'s long-term returns with dividends reinvested. Over 10 years, the total return is -81.5% (-15.5% CAGR) — $10,000 would have grown to $1,853. Over 20 years: -81.5% total return (-8.1% CAGR) — $10,000 → $1,853. Over 30 years: -81.5% total return (-5.5% CAGR) — $10,000 → $1,853. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was OVID's best and worst year?

Ovid Therapeutics Inc.'s best calendar year was 2025 with a total return of 70.1%. Its worst year was 2018 with a total return of -75.3%. This range shows the volatility investors should expect — the difference between the best and worst year is 145.5 percentage points.

How much would $100/month in OVID be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →